UCB NORDIC A/S: Financial statements 2020
CVR: 26688949
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
UCB NORDIC A/S (CVR 26688949) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 46,217,000 and a net result of DKK 3,721,000 compared with DKK 3,591,000 the year before. That is an increase of 16.9% compared with the year before. Equity in the 2020 report amounted to DKK 11,094,000. The solvency ratio was 18.3%. The company had 31 employees in the financial year.
- Gross Profit
- DKK 46,217,000
- Profit/Loss
- DKK 3,721,000
- Equity
- DKK 11,094,000
- Total Assets
- DKK 60,523,000
- Employees
- 31
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 46.2M | 3.7M | 11.1M | 31 |
| 2019 | - | 39.5M | 3.6M | 10.6M | 26 |
| 2018 | - | 34.6M | 3.3M | 10.3M | 24 |
| 2017 | - | 34.8M | 3.7M | 10.6M | 23 |
| 2016 | - | -35.5M | 3.7M | 10.4M | 25 |
Official annual report
How creditworthy is UCB NORDIC A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of November 20, 2020, is registered as an owner of UCB NORDIC A/S with an ownership share of 100%.
UCB NORDIC A/S has published its annual report for 2019. Gross profit came to DKK 39,541,000, and the net result was DKK 3,591,000.
About UCB NORDIC A/S
UCB NORDIC A/S is a Danish company of the type Aktieselskab based in København S, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named UCB NORDICS ApS and CELLTECH NORDIC ApS. The management consists of Mari-Ann Retz. The board consists of Laura Ann Byram (chair), Christina Dyreborg Jeppesen and Jaana Mattila. The company is owned by UCB Pharma SA. The company has 48 employees (2026). In 2025, the company reported a gross profit of DKK 88,278,000 and a net result of DKK 6,014,000 compared with DKK 5,226,000 the year before. Equity in the 2025 report amounted to DKK 18,047,000.